The blood-brain barrier and bilirubin encephalopathy

Area of Science:

• Neuroscience
• Biochemistry
• Neonatology

Background:

• Bilirubin encephalopathy pathogenesis is multifactorial.
• Key factors include blood-brain barrier (BBB) transport, unconjugated bilirubin levels, and serum binding, but their relative importance is unclear.
• The BBB normally limits bilirubin entry, but disruption can increase risk.

Purpose of the Study:

• To elucidate the multifactorial pathogenesis of bilirubin encephalopathy.
• To understand the roles of the blood-brain barrier, bilirubin levels, and albumin binding in bilirubin neurotoxicity.
• To explore maturational changes in brain permeability and their protective effects.

Main Methods:

• Literature review and synthesis of existing research on bilirubin transport and neurotoxicity.
• Analysis of factors influencing bilirubin passage across the blood-brain barrier.
• Examination of the impact of albumin binding and tissue susceptibility on bilirubin toxicity.

Main Results:

• Bilirubin transport across the BBB and delivery to neurons are critical steps in encephalopathy.
• High serum bilirubin levels alone do not guarantee rapid brain entry; unbound bilirubin is key.
• Drug-induced displacement of bilirubin from albumin can accelerate brain deposition.
• Maturational changes may offer protection, while BBB disruption (e.g., by hypoxia) facilitates bilirubin entry.
• Albumin and neuronal binding affinities determine the extent of toxic tissue bilirubin load.

Conclusions:

• Bilirubin encephalopathy results from a complex interplay of factors, not solely high bilirubin levels.
• The integrity and permeability of the blood-brain barrier significantly influence bilirubin neurotoxicity.
• Further research is needed to fully understand the dynamics of bilirubin transport and deposition in the brain, especially in vulnerable neonates.